Home›People›John McEleney
JM

John McEleney

Director at Verve. Also a director at Prometheus Therapeutics, NeuroFine and Deinde Medical.

DirectorPublic companyRoles at 4 startups
Updated Nov 10, 2026·Latest SEC filing May 29, 2026·Suggest an edit

About John McEleney

John McEleney is a director at Verve.

Form D filings also name John McEleney as a director at Prometheus Therapeutics, NeuroFine and Deinde Medical.

John McEleney reports to the SEC as a director of 2 public companies: Stratasys (SSYS) and Stratasys (SSYS).

John McEleney first appears on SEC filings in 2007.

Experience

This experience comes from John McEleney's profile and from SEC filings. For roles taken from filings, the years are when the filings name John McEleney in the role, so the role may have started earlier or lasted longer.

Verve, Inc. Current
Director
2023 – Present · Cambridge, MA
Makes wearable lifting assistance devices for workers who repeatedly lift objects.
Akselos Current
Chairman
2023 – Present
Deinde Medical Corp. Current
Director
2019 – Present · Miramar, FL
Onshape Inc. Current
Co-Founder and Former CEO
2012 – Present
Stratasys Ltd. Current
Director
2008 – Present · Public company (SSYS)
Prometheus Therapeutics Inc.
Director
2025 – 2026 · Miramar, FL
Develops light-based treatment technology for people with vascular diseases, including brain aneurysms.
NeuroFine Corp.
Director
2021 – 2026 · Miramar, FL
InNeuroCo
Former Board Member
2014 – 2023
Newforma
Former Board Member
2004 – 2013
Stratasys Inc.
Director
2007 – 2012 · Public company (SSYS)
CloudSwitch
CEO
2009 – 2012
SolidWorks
CEO
1996 – 2007
Computervision
Marketing
1989 – 1995

Key Colleagues at Startups

The people John McEleney works with at each company, as listed on that company's latest Form D.

Verve, Inc. · Form D, May 29, 2026
IB
Ignacio Galiana Bujanda
Chief Executive Officer and director
AC
CW
Conor Walsh
Director
DG
SE
AP
Andrew Payne
Director
Prometheus Therapeutics Inc. · Form D/A, Apr 15, 2026
BN
Bernie Navarro
Executive officer
Baruch Lieber
Baruch Lieber
President & CSO, director
Ajay Wakhloo
Ajay Wakhloo
CEO and director
NeuroFine Corp. · Form D, Apr 8, 2026
Ajay Wakhloo
Ajay Wakhloo
Chief Executive Officer and director
DS
BN
Bernie Navarro
Executive officer
ML
Deinde Medical Corp. · Form D, Nov 12, 2025
BN
Bernie Navarro
Executive officer
Ajay Wakhloo
Ajay Wakhloo
Director
ML
Marc Litzenberg
Chief Executive Officer and director

Sources

  1. SECVerve, Inc. Form D, filed May 29, 2026
  2. SECPrometheus Therapeutics Inc. Form D/A, filed Apr 15, 2026
  3. SECNeuroFine Corp. Form D, filed Apr 8, 2026
  4. SECDeinde Medical Corp. Form D, filed Nov 12, 2025
  5. SECForms 3, 4 and 5 filed by John McEleney (SEC filer 1421477)